Form 4: L3Harris CEO Exercises Options, Sells Shares in Pre-Arranged Transaction

L3Harris Technologies CEO Christopher E. Kubasik exercised stock options and subsequently sold 72,000 shares of common stock for a significant gain under a Rule 10b5-1 plan.

Summary

• Christopher E. Kubasik, Chair and CEO of L3Harris Technologies, Inc., executed a transaction on July 29, 2025, involving the exercise of stock options and the subsequent sale of common stock.
• Kubasik acquired 72,000 shares of common stock by exercising non-qualified stock options at an exercise price of $149.31 per share.
• Immediately following the exercise, he sold all 72,000 shares at a weighted average price of $271.14 per share, with prices ranging from $269.92 to $272.31.
• The transaction was conducted pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following these transactions, Kubasik directly beneficially owns 145,577.82 shares of common stock and indirectly owns 30,000 shares through a grantor retained annuity trust.
• He also retains 40,138 non-qualified stock options.
• The direct beneficial ownership includes 5.37 shares acquired through the Issuer's retirement plan as of June 27, 2025.

Sentiment

Score: 7

Explanation: The filing reports a routine, pre-planned insider transaction where the CEO exercised options and sold shares for a significant profit. This is generally positive for the individual and reflects past stock appreciation, but the act of selling shares, even under a 10b5-1 plan, can sometimes be viewed with slight neutrality or mild concern by some investors, though it's a common and expected part of executive compensation. The substantial profit indicates good past performance of the stock.

Positives

• The sale price of $271.14 per share is significantly higher than the exercise price of $149.31, indicating a substantial gain for the insider.
• The transaction was conducted under a Rule 10b5-1 plan, which suggests a pre-planned, non-discretionary sale, often viewed positively as it mitigates concerns about trading on inside information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it might suggest a lack of confidence in future stock price appreciation, although this is a common practice for executive compensation and liquidity.

Future Outlook

NA

Industry Context

This is a routine insider transaction for executive compensation and liquidity, common across all industries, including the defense and aerospace sector where L3Harris operates. It does not inherently reflect specific industry trends beyond general executive compensation practices.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans for executive stock transactions is a standard practice among publicly traded companies, including peers in the defense and aerospace industry such as Lockheed Martin (LMT), Raytheon Technologies (RTX), and Northrop Grumman (NOC), to manage insider trading compliance and provide liquidity for executives.
• The significant difference between the exercise price ($149.31) and the sale price ($271.14) is typical for long-held stock options that have appreciated substantially, reflecting the company's stock performance over the option's vesting period.

Stakeholder Impact

• Shareholders: The transaction provides transparency regarding executive stock holdings and compensation. The sale itself does not directly impact the company's operations or financial health, but a large insider sale could sometimes be interpreted by some as a signal, though mitigated by the 10b5-1 plan. The significant profit for the CEO reflects positive stock performance, which benefits all shareholders.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a pre-planned, routine insider transaction where the CEO exercised stock options and sold shares for a substantial profit. Such transactions are common for executive compensation and liquidity purposes and do not typically indicate a change in the company's fundamental outlook or performance. The fact that it was executed under a Rule 10b5-1 plan further suggests it was a scheduled event rather than a discretionary sale based on new information. Therefore, this specific filing alone does not provide a basis for a "buy" or "sell" recommendation, as it reflects past stock appreciation and a standard executive compensation event. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

L3Harris Technologies, LHX, Christopher E. Kubasik, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Executive Compensation, Defense Industry, Aerospace